NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding NexImmune, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 42 | 47 | +5 |
| Shares | 9.71M | 10.6M | +881.1K (+9.1%) |
| Value | $119.0M | $160.3M | +$41.4M (+34.8%) |
New holders (12)
Institutions that held NexImmune, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| First Manhattan Co | 147,159 | $2.23M | 0.01% |
| Kingdon Capital Management, L.L.C. | 117,962 | $1.79M | 0.31% |
| Edgewood Management LLC | 56,015 | $848.0K | 0.00% |
| Rockefeller Capital Management L.P. | 27,860 | $421.0K | 0.00% |
| Raymond James & Associates | 25,957 | $393.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 10,464 | $158.0K | 0.00% |
| Rhumbline Advisers | 10,332 | $156.0K | 0.00% |
| MetLife Investment Management | 7,704 | $116.6K | 0.00% |
| SG Americas Securities, LLC | 7,524 | $114.0K | 0.00% |
| Metropolitan Life Insurance Co | 5,828 | $88.2K | 0.00% |
| US Bancorp | 131 | $2.00K | 0.00% |
| Signaturefd, LLC | 29 | $0 | 0.00% |
Sold out (7)
Institutions that held NexImmune, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| DSAM Partners (London) Ltd | 89,500 | $1.46M |
| Walleye Capital LLC | 32,140 | $525.0K |
| Johns Hopkins University | 26,919 | $439.0K |
| Alyeska Investment Group, L.P. | 11,417 | $186.0K |
| Russell Investments Group, Ltd. | 2,432 | $39.0K |
| UBS Group AG | 1,080 | $18.0K |
| State of Wyoming | 771 | $13.0K |